1074
T. K. Pradhan, A. Hassner
LETTER
(12) Hassner, A.; Pradhan, T. K. Tetrahedron Lett. 2006, 47,
5511.
(18) ARF Reaction of exo-syn-Isomer of 1a
A solution of exo-syn-isomer of compound 1a (0.512 g, 20
mmol), diacetoxy iodobenzene (1.28 g, 40 mmol) and iodine
(1.52 g, 60 mmol) in CH2Cl2 (60 mL) taking in a round-
bottomed flask was irradiated under one 100 W tungsten
filament lamp for 2 h at r.t. The mixture was washed with
NaHSO3 solution (3 × 30 mL), brine (2 × 30 mL) and dried
(Na2SO4). Solvent was removed under reduced pressure and
the residue was chromatographed to obtain the colorless oily
compound 5 as a mixture of diastereomers in an almost 1:1
ratio, and compound 6 [eluant: EtOAc–n-hexane (1:4)].
Compound 5 (diastereomeric mixture): 1H NMR (300 MHz,
CDCl3): d = 9.63 (d, J = 1.2 Hz, 1 H, CHO), 9.59 (d, J = 1.2
Hz, 1 H, CHO), 5.28–5.22 (m, 2 H, CHO), 4.28–4.19 (m, 4
H, CH2O), 2.80 (dd, J = 8.0, 15.0 Hz, 1 H), 2.66–2.56 (m, 3
H), 2.48–2.33 (m, 6 H), 2.04–1.97 (m, 5 H), 1.92–1.60 (m, 8
H), 1.47–1.32 (m, 1 H), 1.25–1.20 (m, 6 H). 13C NMR:
d = 200.7, 200.5 (CHO), 172.3 (O–C=O), 170.2 (O–C=O),
71.8, 71.2 (CHO), 62.3 (OCH2), 56.8, 56.3 (CHCHO), 44.7
(C–I), 42.1, 40.9, 37.1, 37.0, 30.4, 29.5, 23.0, 21.7, 21.2
(COCH3), 13.8. (CH3CH2). HRMS (CI, CH4): m/z (%) calcd
for C13H19IO5: 382.028; found: 383.033 (5) [MH]+, 355.013
(25) [MH – CO]+, 339.010 (40) [M – CH3CO]+.
(13) (a) Buchanan, G. L.; Mc Lay, G. W. Tetrahedron 1966, 25,
1521. (b) Buchanan, G. L.; Mc Killop, A.; Raphael, R. A. J.
Chem. Soc. 1965, 833. (c) Kraus, W.; Patzelt, H.; Sawitzki,
G. Tetrahedron Lett. 1978, 445. (d) Simon, C.; Peyronel, J.-
F.; Clerc, F.; Rodriguez, J. Eur. J. Org. Chem. 2002, 19,
3359.
(14) (a) Courtneidge, J. L.; Lusztyk, J.; Page, D. Tetrahedron
Lett. 1994, 35, 1003. (b) Gonzalez, C. C.; Leon, E. I.;
Riesco-Fagundo, C.; Suarez, E. Tetrahedron Lett. 2003, 44,
6347. (c) Gonzalez, C. C.; Kennedy, A. R.; Leon, E. I.;
Riesco-Fagundo, C.; Suarez, E. Angew. Chem. Int. Ed. 2001,
40, 2326.
(15) Synthesis of 4-Acetoxy-8-oxobicyclo[3.3.1]octane-1-
carboxylic Acid Ethyl Ester(4a) – Analytical Data
endo-Isomer: 1H NMR (300 MHz, CDCl3): d = 4.93 (ddd,
J = 9, 6, 3 Hz, 1 H, CHO), 4.13 (q, J = 7 Hz, 2 H, CH2O),
2.65–2.62 (m, 1 H), 2.59–2.45 (m, 1 H), 2.07–1.82 (m, 9 H),
1.78–1.59 (m, 1 H), 1.19 (t, J = 7 Hz, 3 H, CH2CH3). 13
C
NMR: d = 208.9 (C=O), 170.8 (O–C=O), 169.6 (O–C=O),
74.2 (C4HO), 61.2 (OCH2), 56.8 (C1), 50.6 (C5H), 30.8, 26.8,
23.6, 21.0 (COCH3), 17.0, 14.1 (CH3CH2). HRMS (CI,
CH4): m/z (%) calcd for C13H18O5: 254.115; found: 254.123
(27) [M]+, 255.119 (45) [MH]+.
Compound 6 (oil): 1H NMR (300 MHz, CDCl3): d = 9.33 (s,
1 H, CHO), 6.85 (m, 1 H, CH=C), 4.28 (q, J = 7 Hz, 2 H,
exo-Isomer: 1H NMR (300 MHz, CDCl3): d = 5.15 (br s, 1 H,
CHO), 4.19–4.15 (m, 2 H, CH2O), 2.61–2.42 (m, 3 H), 2.08–
1.92 (m, 7 H), 1.78–1.61 (m, 2 H), 1.19 (t, J = 7 Hz, 3 H,
CH2CH3). 13C NMR: d = 209.9 (C=O), 170.9 (O–C=O),
170.2 (O–C=O), 78.7 (C4HO), 61.3 (OCH2), 57.0 (C1), 48.6
(C5H), 33.8, 25.8, 23.3, 21.1 (COCH3), 19.2, 14.2
(CH3CH2). HRMS (CI, CH4): m/z (%) calcd for C13H18O5:
254.115; found: 255.120 (33) [MH]+.
CH2O), 2.70–2.28 (m, 8 H), 1.30 (t, J = 7 Hz, 3 H, CH3). 13
NMR: d = 193.4 (CHO), 172.4 (O–C=O), 154.2 (CH=),
C
146.0 (C=), 62.2 (OCH2), 48.3 (C–I), 39.5, 39.3, 27.6, 21.9,
13.8. (CH3). HRMS (CI, CH4): m/z (%) calcd for C11H15IO3:
322.007; found: 320.999 (23) [M – H]+, 194.076 (27) [M –
HI]+, 193.068 (45) [M – H – HI]+.
Compound 7: 1H NMR (300 MHz, CDCl3): d = 9.55 (br s, 1
H, CHO), 9.52 (br s, 1 H, CHO), 5.59–5.51 (m, 2 H, CHO),
4.28–4.16 (m, 4 H, CH2O), 2.94 (dd, J = 7, 15 Hz, 1 H),
2.75–2.09 (m, 10 H), 2.01–1.78 (m, 11 H), 1.74–1.45 (m, 2
H), 1.27–1.22 (m, 6 H). 13C NMR: d = 200.1, 200.1 (CHO),
172.7, 172.3, 170.0, 169.9, 70.3, 70.2, 62.1, 62.1 (OCH2),
55.8, 55.5 (CHCHO), 46.0, 45.0 (C–I), 41.9, 40.9, 36.3,
36.3, 30.0, 29.0, 21.0, 20.9, 20.9, 19.3, 13.6, 13.6.
(16) Synthesis of 4-Acetoxy-8-hydroxybicyclo[3.2.1]octane-1-
carboxylic Acid Ethyl Ester(1a) by NaBH4/EtOH
Reduction of 4a – Analytical Data
exo-syn-Isomer of 1a: 1H NMR (300 MHz, CDCl3): d = 4.90
(br s, 1 H, CHO), 4.22 (d, J = 4.5 Hz, 1 H, HOCH), 4.12 (q,
J = 7.0 Hz, 2 H, CH2O), 2.98 (br s, 1 H, OH), 2.43–2.38 (m,
1 H), 2.22–2.11 (m, 1 H), 2.04–1.95 (m, 4 H), 1.90–1.58 (m,
5 H), 1.32–1.26 (m, 1 H), 1.20 (t, J = 7.0 Hz, 3 H, CH2CH3).
13C NMR: d = 176.7 (O–C=O), 170.5 (O–C=O), 75.8
(CHO), 70.1 (CHO), 60.7 (OCH2), 50.1 (C1), 42.3 (C5H),
29.1, 25.9, 23.6, 21.4 (COCH3), 19.2, 14.2 (CH3CH2).
HRMS (CI, CH4): m/z (%) calcd for C13H20O5: 256.131;
found: 257.142 (11) [MH]+, 197.117 (34) [MH – HOAc]+,
196.110 (43) [M – HOAc]+, 150.070 (51) [M – HOAc –
EtOH]+.
(CH3CH2). HRMS (CI, CH4): m/z (%) calcd for C13H19IO5:
382.028; found: 382.029 (17) [M]+, 383.033 (23) [MH]+.
(19) In the seven-membered-ring analogue 1a the C-3 hydrogen
is less readily accessible for radical abstraction.
(20) Compound 13: 1H NMR (300 MHz, CDCl3): d = 9.39 (s, 1
H, CHO), 6.69 (dd, J = 2.1, 3.3 Hz, 1 H, CH=CH2), 4.20–
4.10 (m, 2 H, CH2O), 2.68 (dt, J = 16.0, 5.0 Hz, 1 H), 2.54–
2.46 (m, 1 H), 2.34–2.28 (m, 1 H), 2.18–2.07 (m, 1 H), 2.95–
1.85 (m, 1 H), 1.66 (dd, J = 10.0, 4.0 Hz, 1 H), 1.40–1.21 (m,
6 H), 0.82 (dd, J = 4.0, 6.6 Hz, 1 H). 13C NMR: d = 194.6
(CHO), 174.0 (O–C=O), 149.8 (CH=), 143.1 (C=), 60.9
(OCH2), 29.7 (C–I), 28.3, 25.4, 23.3, 22.7, 20.1, 14.2 (CH3).
HRMS (CI, CH4): m/z (%) calcd for C12H17IO3: 336.022;
found: 336.023 (24) [M]+, 337.025 (47) [MH]+.
(17) Aspinall, H. C.; Greeves, N.; Valla, C. Org. Lett. 2005, 7,
1919.
Synlett 2007, No. 7, 1071–1074 © Thieme Stuttgart · New York